au.\*:(%22Paget Foundation for Paget%27s Disease of Bone and Related Disorders%22)
Results 1 to 25 of 18443
Selection :
Proceedings of the Symposium Second North American Symposium on Skeletal Complications of MalignancyCancer. 2000, Vol 88, Num 12, issn 0008-543X, 226 p., SUPConference Proceedings
Proceedings of the Third International Symposium on Paget's Disease, Napa, California, U.S.A., November 29-30, 1998Journal of bone and mineral research (Print). 1999, Vol 14, issn 0884-0431, 109 p., SUP2Conference Proceedings
Symposium Skeletal Complications of MalignancyCancer. 1997, Vol 80, Num 8, issn 0008-543X, 180 p., SUPConference Proceedings
Bisophosphonates : pharmacologyFLEISCH, H.Seminars in arthritis and rheumatism. 1994, Vol 23, Num 4, pp 261-262, issn 0049-0172Conference Paper
Calcitonin : history and prospects : a personal viewWALLACH, S.Seminars in arthritis and rheumatism. 1994, Vol 23, Num 4, pp 256-260, issn 0049-0172Conference Paper
Biochemical and scintigraphic assessment of Paget's diseaseBURCKHARDT, P.Seminars in arthritis and rheumatism. 1994, Vol 23, Num 4, pp 237-239, issn 0049-0172Conference Paper
Moving disease biology from the lab to the clinicANDERSON, Kenneth C.Cancer. 2003, Vol 97, Num 3, pp 796-801, issn 0008-543X, 6 p., SUPConference Paper
The development and function of the skeleton and bone metastasesRODAN, Gideon A.Cancer. 2003, Vol 97, Num 3, pp 726-732, issn 0008-543X, 7 p., SUPConference Paper
Goals of treatment for Paget's disease of boneSIRIS, E. S.Journal of bone and mineral research (Print). 1999, Vol 14, pp 49-52, issn 0884-0431, SUP2Conference Paper
Biochemical markers of bone turnover in Paget's disease of boneDELMAS, P. D.Journal of bone and mineral research (Print). 1999, Vol 14, pp 66-69, issn 0884-0431, SUP2Conference Paper
Radiation for Bone MetastasesJANJAN, N. A.Cancer. 1997, Vol 80, Num 8, pp 1628-1645, issn 0008-543X, SUPConference Paper
Antitumor effects of bisphosphonatesGREEN, Jonathan R.Cancer. 2003, Vol 97, Num 3, pp 840-847, issn 0008-543X, 8 p., SUPConference Paper
Current and future status of adjuvant therapy for breast cancerCOLEMAN, Robert E.Cancer. 2003, Vol 97, Num 3, pp 880-886, issn 0008-543X, 7 p., SUPConference Paper
Paget's disease : Treatment results and expectations with present therapiesMEUNIER, P. J.Journal of bone and mineral research (Print). 1999, Vol 14, pp 70-73, issn 0884-0431, SUP2Conference Paper
Bisphosphonates in prostate carcinomaADAMI, S.Cancer. 1997, Vol 80, Num 8, pp 1674-1679, issn 0008-543X, SUPConference Paper
Mechanisms of bone metastasisMUNDY, G. R.Cancer. 1997, Vol 80, Num 8, pp 1546-1556, issn 0008-543X, SUPConference Paper
Parathyroid hormone-related protein and bone metastasesGUISE, T. A.Cancer. 1997, Vol 80, Num 8, pp 1572-1580, issn 0008-543X, SUPConference Paper
Skeletal complications of malignancyCOLEMAN, R. E.Cancer. 1997, Vol 80, Num 8, pp 1588-1594, issn 0008-543X, SUPConference Paper
Diagnosis and management of treatment-related osteoporosis in men with prostate carcinomaSMITH, Matthew R.Cancer. 2003, Vol 97, Num 3, pp 789-795, issn 0008-543X, 7 p., SUPConference Paper
Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implicationsCHUNG, Leland W. K.Cancer. 2003, Vol 97, Num 3, pp 772-778, issn 0008-543X, 7 p., SUPConference Paper
Molecular mechanisms of osteolytic bone metastasesGUISE, T. A.Cancer. 2000, Vol 88, Num 12, pp 2892-2898, issn 0008-543X, SUPConference Paper
Bisphosphonates and breast carcinoma : Present and futureLIPTON, A.Cancer. 2000, Vol 88, Num 12, pp 3033-3037, issn 0008-543X, SUPConference Paper
Hormone therapy for patients with prostate carcinomaKLOTZ, L.Cancer. 2000, Vol 88, Num 12, pp 3009-3014, issn 0008-543X, SUPConference Paper
Mechanisms and management of bone painPAYNE, R.Cancer. 1997, Vol 80, Num 8, pp 1608-1613, issn 0008-543X, SUPConference Paper
Clinical research updateBODY, J. J.Cancer. 1997, Vol 80, Num 8, pp 1699-1701, issn 0008-543X, SUPConference Paper